Trimi GLP-1 prices
Compounded semaglutide and tirzepatide telehealth (Arora Health clinicians, BelieveRx 503A pharmacy) at one price per plan length at every dose, no membership fee; all 50 states and DC (503A, not FDA-approved). Trimi has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide $175/mo; Compounded tirzepatide $235/mo. Plan terms, fees and the check date are listed with each quote.
Search by medication, provider or treatment goal. Examples follow.
Tirzepatide · Compounded
1 offers · US self-pay
Price conditions & source
Advertised price: monthly plan that renews until turned off; $597 every 3 months ($199/mo), $1,050 upfront for 6 months ($175/mo) or $1,500 upfront for 12 months ($125/mo); the same price at every dose; medication if prescribed, injection supplies, provider care and shipping included, no membership, consultation or shipping fee
Maintenance terms: Trimi states the same price at every prescribed dose.
Weekly injection. The 6- and 12-month prepaid plans do not auto-renew. New patients can take $50 off the first month with a code on Trimi's promo page. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
Trimi GLP-1 cost: common questions
How much does semaglutide cost through Trimi?
Compounded semaglutide: $175/mo (monthly plan that renews until turned off; $435 every 3 months ($145/mo), $720 upfront for 6 months ($120/mo) or $1,188 upfront for 12 months ($99/mo); the same price at every dose; medication if prescribed, injection supplies, provider care and shipping included, no membership, consultation or shipping fee). Checked Oct 21, 2026; each quote links its source in the table. Compounded semaglutide is not an FDA-approved product.
How much does tirzepatide cost through Trimi?
Compounded tirzepatide: $235/mo (monthly plan that renews until turned off; $597 every 3 months ($199/mo), $1,050 upfront for 6 months ($175/mo) or $1,500 upfront for 12 months ($125/mo); the same price at every dose; medication if prescribed, injection supplies, provider care and shipping included, no membership, consultation or shipping fee). Checked Oct 21, 2026; each quote links its source in the table. Compounded tirzepatide is not an FDA-approved product.
Does Trimi offer FDA-approved GLP-1 medication or compounded versions?
The Trimi offers tracked here are compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
When were Trimi prices last checked?
Each quote carries its own check date and links the page it was read from: Oct 21, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.